Kshitija Kale, MD, PhD successfully defended her doctoral thesis on November 9th, 2026.
She was enrolled in the Experimental Pathology Graduate Program in the fall of 2021 and she conducted her doctoral thesis work in the laboratory of Nitin Karandikar, MD, PhD. Her thesis, Cytokine-driven functional heterogeneity of human Th17 cells: Implications for Th17 Pathogenicity, Effector Resistance to Immune Suppression and T-cell Metabolic Rewiring, focuses on restoration of immune balance by studying the role of cytokines in T-helper 17 cell generation and function.
Th17 cells are immune cells that drive inflammation in autoimmune diseases. Depending on their environment, they can become either harmful or less aggressive. She found that the cytokine TGF-β1 makes Th17 cells resistant to regulation by other immune cells, even overriding signals that normally make them harmful. Through gene analysis and animal models, she showed that TGF-β1 rewires Th17 behavior, providing insight into how these cells may contribute to autoimmune disease relapses.
Kshitija’s thesis committee included Drs. Vladimir Badovinac, Ali Jabbari, Scott Lieberman, and Andrean Simons-Burnett. In addition to her doctoral work, Kshitija interned at the Scientific Editing and Research Communication Core (SERCC) and served on the executive board of the Graduate Student Senate and Government for two consecutive years. She was involved in several collaborative research projects in the last five years.
She is a new inductee into the Pathology Residency Program – Physician Scientist Training Pathway track at the University of Iowa and looks forward to training in Clinical Pathology and Transfusion Medicine.